SHARLEEZ MEDICS LIMITED
Registered number: 12619241
Balance Sheet
as at 31 May 2025
Notes 2025
£
Fixed assets
Tangible assets 3 631
Current assets
Cash at bank and in hand 83,626
Creditors: amounts falling due within one year 4 (13,375)
Net current assets 70,251
Total assets less current liabilities 70,882
Creditors: amounts falling due after more than one year 5 (30,865)
Net assets 40,017
Capital and reserves
Called up share capital 120
Profit and loss account 39,897
Shareholders' funds 40,017
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges her responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Dr Mariyam Malik
Director
Approved by the board on 6 September 2025
SHARLEEZ MEDICS LIMITED
Notes to the Accounts
for the year ended 31 May 2025
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 5 years
Fixtures, fittings, tools and equipment over 5 years
2 Employees 2025
Number
Average number of persons employed by the company 1
3 Tangible fixed assets
Plant and machinery etc
£
Cost
Additions 789
At 31 May 2025 789
Depreciation
Charge for the year 158
At 31 May 2025 158
Net book value
At 31 May 2025 631
4 Creditors: amounts falling due within one year 2025
£
Taxation and social security costs 6,875
Other creditors 6,500
13,375
5 Creditors: amounts falling due after one year 2025
£
Other creditors 30,865
6 Other information
SHARLEEZ MEDICS LIMITED is a private company limited by shares and incorporated in England. Its registered office is:
21 Jubilee Avenue
Broomfield
Chelmsford
Essex
CM1 7HE
SHARLEEZ MEDICS LIMITED 12619241 false 2024-06-01 2025-05-31 2025-05-31 VT Final Accounts April 2025 Dr Mariyam Malik No description of principal activity 12619241 2024-06-01 2025-05-31 12619241 bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 12619241 bus:AuditExemptWithAccountantsReport 2024-06-01 2025-05-31 12619241 bus:Director40 2024-06-01 2025-05-31 12619241 countries:England 2024-06-01 2025-05-31 12619241 bus:FRS102 2024-06-01 2025-05-31 12619241 bus:FilletedAccounts 2024-06-01 2025-05-31 12619241 2025-05-31 12619241 core:WithinOneYear 2025-05-31 12619241 core:AfterOneYear 2025-05-31 12619241 core:ShareCapital 2025-05-31 12619241 core:RetainedEarningsAccumulatedLosses 2025-05-31 12619241 2024-05-31 iso4217:GBP xbrli:pure